2. Academic Validation
  3. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant

Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant

  • Am J Med. 2017 May;130(5):e195-e197. doi: 10.1016/j.amjmed.2016.11.029.
Shannon W Finks 1,  Kelly C Rogers 1
Affiliations

Affiliation

  • 1 Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis.
PMID: 28011314 DOI: 10.1016/j.amjmed.2016.11.029
Figures
Products